Thomas P. Griener

In vivo supramolecular templating enhances the activity of multivalent ligands: A potential therapeutic against the <i>Escherichia coli</i> O157 AB ₅ toxins

Pavel I. Kitov, George L. Mulvey, Thomas P. Griener et al. · Proceedings of the National Academy of Sciences · 2008 · 82 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17

The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin

Romney M. Hyland, Jiangxiao Sun, Thomas P. Griener et al. · Cellular Microbiology · 2007 · 64 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study

Alejandra Ugarte-Torres, Mark R. Gillrie, Thomas P. Griener et al. · Clinical Infectious Diseases · 2018 · 55 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Human Serum Amyloid P Component Protects against<i>Escherichia coli</i>O157:H7 Shiga Toxin 2 In Vivo: Therapeutic Implications for Hemolytic‐Uremic Syndrome

Glen D. Armstrong, George L. Mulvey, Paola Marcato et al. · The Journal of Infectious Diseases · 2006 · 52 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Recombinant Shiga Toxin B-Subunit-Keyhole Limpet Hemocyanin Conjugate Vaccine Protects Mice from Shigatoxemia

Paola Marcato, Thomas P. Griener, George L. Mulvey et al. · Infection and Immunity · 2005 · 50 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17